UL Solutions Other Income (Expense) increased by 75.0% to -$1.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 66.7%, from -$3.00M to -$1.00M. Over 2 years (FY 2022 to FY 2025), Other Income (Expense) shows relatively stable performance with a -4.3% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$3.00M | -$3.00M | -$3.00M | -$3.00M | $5.00M | $11.00M | -$7.00M | $5.00M | -$3.00M | $21.00M | $0.00 | -$3.00M | -$4.00M | $0.00 | -$4.00M | -$1.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +266.7% | +120.0% | -163.6% | +171.4% | -160.0% | +800.0% | -100.0% | — | -33.3% | +100.0% | — | +75.0% |
| YoY Change | — | — | — | — | +266.7% | +466.7% | -133.3% | +266.7% | -160.0% | +90.9% | +100.0% | +0.0% | -119.0% | — | — | +66.7% |